Literature DB >> 1382171

Regulation of cerebral blood flow in health and disease.

S Strandgaard1, O B Paulson.   

Abstract

A review is given of the normal regulation of cerebral blood flow (CBF) and its pathophysiology in hypertension and stroke. In otherwise healthy hypertensive patients, the absolute level of CBF is the same as in normal subjects. CBF autoregulation, however, is shifted towards higher pressure, thus impairing the tolerance to hypotension. In most patients, this does not interfere with the beneficial effect of treatment, i.e., stroke prevention. Cerebral ischemia, however, may be provoked by overzealous pressure lowering in selected clinical settings: initial or intensified treatment of very severe hypertension, treatment of hypertension in the elderly, and treatment of hypertension in acute stroke. In the latter, a complicated sequence of brain ischemia and hyperemia makes antihypertensive intervention difficult in the early phase, when blood pressure is probably best allowed to decrease spontaneously.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1382171     DOI: 10.1097/00005344-199219006-00014

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  13 in total

Review 1.  Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications.

Authors:  Juan M Saavedra; Enrique Sánchez-Lemus; Julius Benicky
Journal:  Psychoneuroendocrinology       Date:  2010-10-29       Impact factor: 4.905

Review 2.  Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders.

Authors:  Juan M Saavedra
Journal:  Clin Sci (Lond)       Date:  2012-11       Impact factor: 6.124

Review 3.  Therapies to Reduce Blood Pressure Acutely.

Authors:  Joseph B Miller; Harish Kinni; Ahmed Amer; Phillip D Levy
Journal:  Curr Hypertens Rep       Date:  2016-06       Impact factor: 5.369

Review 4.  Transcranial Doppler in autonomic testing: standards and clinical applications.

Authors:  Lucy Norcliffe-Kaufmann; Brahyan Galindo-Mendez; Ana-Lucia Garcia-Guarniz; Estibaliz Villarreal-Vitorica; Vera Novak
Journal:  Clin Auton Res       Date:  2017-08-18       Impact factor: 4.435

Review 5.  Critical care of acute ischemic stroke.

Authors:  W Hacke; R Stingele; T Steiner; V Schuchardt; S Schwab
Journal:  Intensive Care Med       Date:  1995-10       Impact factor: 17.440

6.  MRI evaluation of cerebrovascular reactivity in obstructive sleep apnea.

Authors:  Pei-Hsin Wu; Ana E Rodríguez-Soto; Zachary B Rodgers; Erin K Englund; Andrew Wiemken; Michael C Langham; John A Detre; Richard J Schwab; Wensheng Guo; Felix W Wehrli
Journal:  J Cereb Blood Flow Metab       Date:  2019-07-15       Impact factor: 6.200

7.  MRI evaluation of cerebral metabolic rate of oxygen (CMRO2) in obstructive sleep apnea.

Authors:  Pei-Hsin Wu; Ana E Rodríguez-Soto; Andrew Wiemken; Erin K Englund; Zachary B Rodgers; Michael C Langham; Richard J Schwab; John A Detre; Wensheng Guo; Felix W Wehrli
Journal:  J Cereb Blood Flow Metab       Date:  2022-01-07       Impact factor: 6.960

8.  Potential role for angiotensin-converting enzyme inhibitors in the treatment of glaucoma.

Authors:  Kazuyuki Hirooka; Fumio Shiraga
Journal:  Clin Ophthalmol       Date:  2007-09

Review 9.  Regulation of cerebral blood flow in humans: physiology and clinical implications of autoregulation.

Authors:  Jurgen A H R Claassen; Dick H J Thijssen; Ronney B Panerai; Frank M Faraci
Journal:  Physiol Rev       Date:  2021-03-26       Impact factor: 37.312

10.  Effects of hypercapnia on peripheral vascular reactivity in elderly patients with acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Angela de Matthaeis; Antonio Greco; Mariangela Pia Dagostino; Giulia Paroni; Andrea Fontana; Manlio Vinciguerra; Gianluigi Mazzoccoli; Davide Seripa; Gianluigi Vendemiale
Journal:  Clin Interv Aging       Date:  2014-05-29       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.